BIO Co-Sponsors February FDA/DIA Workshop!

BIO is a key co-sponsor for a key meeting on genomics policy being held by the FDA and the Drug Information Association (DIA).

The meeting is entitled: 5th Workshop in a Series on Pharmacogenomics: Generating and Weighing Evidence in Drug Development and Regulatory Decision Making

It will be held February 2, 2010 8:00AM – February 4, 2010 3:00 pm at the Marriott Bethesda North Hotel.

Some of the featured topics of interest include:

· When PGx data will be required during clinical development

· Defining parameters that allow retrospective/prospective analyses to be conducted for regulatory approval of compounds in biomarker defined cohorts

· Case studies in efficacy, safety, and dosing which have integrated PGx

· Translation of genomic information to labels that are useful to prescribers and patients

· Challenges with sample collection for PGx in global development programs and ways to overcome them

· Critical analyses and recommendations for drug diagnostic co-development paradigms which are feasible in the competing hurdles to develop new medicines

· Discussion panel of stakeholders including regulators, industry, third party payers, medical researchers and practitioners

This will be a great workshop for members of BIO to attend as well as other industry companies!